Regulators block Duchenne muscular dystrophy treatment after fatal side-effects outweigh questionable efficacy ...

In this week’s edition of InnovationRx, we look at Halle Berry’s menopause startup, Ambience Healthcare’s $243 million ...

A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...